JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.
Citation:
JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.
JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.
Citation:
JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors[J]. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.
Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors
Classical Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)and selective Cyclooxygenase-2(COX-2)inhibitors present GI damage and diverse side effects for the treatment of inflammatory disease,which limited their clinical development.These compounds with equal
DownLoad: